Lexaria Bioscience has an EPS of $-1.01. In 2022, the company made an earnings per share (EPS) of $-1.24. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$1.01 | -18.55% |
2022 | -$1.24 | 30.53% |
2021 | -$0.95 | -35.37% |
2020 | -$1.47 | - |